EU Extends Review Deadline for Solvay Pharmaceuticals, Inc., Abbott Laboratories (JOBS) Deal

Reuters -- EU regulators extended on Friday their review of U.S. drugmaker Abbott Laboratories' (ABT.N) plan to acquire Belgian peer Solvay Pharmaceuticals (SOLB.BR) after Abbott offered remedies to ease competition concerns.